Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
UK
Telephone: +44 1698794410
E-mail: Nadia.Crockett@nhs.scot
NUTS: UKM
Internet address(es)
Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/
Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Cytokine Modulators
Reference number: NP47920
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications.
• etanercept,
• Infliximab,
• adalimumab,
• methotrexate.
The goods have been split into eight (8) categories, each of which are identified as a ‘Lot’. Full details of each lot are contained in section II.2) of this notice.
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.1.7) Total value of the procurement
Value excluding VAT:
116 335 496.00
GBP
II.2) Description
Lot No: 1
II.2.1) Title
Etanercept
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of Etanercept to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to three (3) framework participants.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Infliximab IV
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of Infliximab IV to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to five (5) framework participants.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
Infliximab Subcutaneous
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of Infliximab Subcutaneous to NHS Scotland. The authority has awarded this lot as a single supplier framework per line to one (1) framework participant.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 4
II.2.1) Title
Adalimumab
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of Adalimumab to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to five (5) framework participants.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 5
II.2.1) Title
Methotrexate (50 mg per 1 ml Concentration) Pre-filled Self Injection Device
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of methotrexate (50 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) framework participants.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 6
II.2.1) Title
Methotrexate (50 mg per 1 ml Concentration) Pre-filled Syringes
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of methotrexate (50 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 7
II.2.1) Title
Methotrexate (25 mg per 1 ml Concentration) Pre-filled Self Injection Device
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of methotrexate (25 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 8
II.2.1) Title
Methotrexate (25 mg per 1 ml Concentration) Pre-filled Syringes
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2020/S 199-483802
Section V: Award of contract
Lot No: 1
Title: Etanercept
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
11/01/2021
V.2.2) Information about tenders
Number of tenders received: 3
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 3
Number of tenders received by electronic means: 3
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Sandoz Ltd
Frimley Business Park, Frimley
Camberley
GU16 7SR
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Pfizer Ltd
Walton Oaks, Dorking Road, Surrey
Tadworth
KT20 7NS
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Biogen Idec Ltd.
Innovation House, 70 Norden Road
Maidenhead
SL4 6AY
UK
NUTS: UKM
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 46 271 726.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 2
Title: Infliximab IV
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
11/01/2021
V.2.2) Information about tenders
Number of tenders received: 5
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 5
Number of tenders received by electronic means: 5
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Pfizer Ltd
Walton Oaks, Dorking Road, Surrey
Tadworth
KT20 7NS
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Merck Sharp and Dohme
Hertford Road
Hoddesdon
EN119BU
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Celltrion Healthcare United Kingdom Ltd
1-7 The Switch
Slough
SL1 1QP
UK
NUTS: UKM
The contractor is an SME:
Yes
V.2.3) Name and address of the contractor
Biogen Idec Ltd.
Innovation House, 70 Norden Road
Maidenhead
SL4 6AY
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Sandoz Ltd
Frimley Business Park, Frimley
Camberley
GU16 7SR
UK
NUTS: UKM
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 18 193 906.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 3
Title: Infliximab Subcutaneous
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
11/01/2021
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Celltrion Healthcare United Kingdom Ltd
1-7 The Switch
Slough
SL1 1QP
UK
NUTS: UKM
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 307 680.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 4
Title: Adalimumab
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
11/01/2021
V.2.2) Information about tenders
Number of tenders received: 5
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 5
Number of tenders received by electronic means: 5
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
AbbVie Ltd
Abbvie House, Vanwall Business Park
Maidenhead
SL6 4UB
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Amgen Ltd
240 cambridge science parl
Cambrdige
CB4 0WD
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Fresenius Kabi Ltd
Cestrian Court, Eastgate Way, Manor Park
Runcorn
WA7 1NT
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Biogen Idec Ltd
Innovation House, 70 Norden Road
Maidenhead
SL4 6AY
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Sandoz Ltd
Frimley Business Park, Frimley
Camberley
GU16 7SR
UK
NUTS: UKM
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 36 167 709.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 5
Title: Methotrexate (50 mg per 1 ml Concentration) Pre-filled Self Injection Device
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
11/01/2021
V.2.2) Information about tenders
Number of tenders received: 2
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 2
Number of tenders received by electronic means: 2
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Accord-UK Ltd
Whiddon Valley
Barnstaple
EX32 8NS
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
medac Pharma LLP
Scion House, Innovation Park
Stirling
FK9 4NF
UK
NUTS: UKM
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 14 775 961.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 6
Title: Methotrexate (50 mg per 1 ml Concentration) Pre-filled Syringes
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
11/01/2021
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Accord UK Ltd
Whiddon Valley
Barnstaple
EX32 8NS
UK
NUTS: UKM
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 390 136.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 7
Title: Methotrexate (25 mg per 1 ml Concentration) pre-filled Self Injection Device
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
11/01/2021
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Nordic Pharma Ltd
Unit 3, Commerce Park, Brunel Road
Theale
RG7 4AB
UK
NUTS: UKM
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 218 102.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 8
Title: Methotrexate (25 mg per 1 ml Concentration) Pre-filled Syringes
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
11/01/2021
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Nordic Pharma Ltd
Unit 3, Commerce Park, Brunel Road
Theale
RG7 4AB
UK
NUTS: UKM
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 317 995.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The estimated values referred to in Section II.I.5) and all lots cover the initial twenty four (24) month duration and the maximum twenty four (24) month extension period.
(SC Ref:642734).
VI.4) Procedures for review
VI.4.1) Review body
Sheriff Court House
27 Chambers Street
Edinburgh
EH1 1LB
UK
E-mail: edinburgh@scotcourts.gov.uk
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
VI.5) Date of dispatch of this notice
11/02/2021